New York, NY -- (SBWire) -- 04/28/2020 --Since the onset of the COVID-19 pandemic a few months ago, the global COVID-19 diagnostics market is witnessing unparalleled growth in terms of revenue. The COVID-19 pandemic has been a life-altering event in human history as it has already claimed more than 207,000 lives and infected more than 2.97 million individuals globally. Since the COVID-19 has no therapeutic or preventive solution till date, testing is the only possible way currently to curb further spread of this infection. Companies have not only ramped up manufacturing of existing COVID-19 diagnostic products but are also conducting active research to introduce novel testing procedures, to further improve the efficiency & accuracy of these tests. The market for COVID-19 diagnostics is anticipated to be skyrocket in the coming months, as countries around the globe plan to amplify the number of tests being conducted significantly. The rapid spread of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can be primarily attributed to the growth of the global COVID-19 diagnostics market. The principal objective behind testing is to prevent further transmission of the virus and isolate individuals suffering from the infection.
If testing, isolation, quarantining & social distancing norms are followed at an acceptable level, it would eventually segregate the infected population and restrict the further proliferation of the disease, till an effective therapeutic or preventive drug/vaccine is introduced. The diagnostic tests used to detect the COVID-19 includes molecular assays, serologic immunoassays and ancillary diagnostic tests. The molecular assay technique, which includes the RT-PCR-based assays, remains the cornerstone in COVID-19 diagnostic testing, owing to its high accuracy. However, serologic immunoassays which include rapid testing kits to detect antigens or antibodies, are gradually witnessing a surge in adoption. The growth of serological immunoassays can be attributed to the simple design of the kits which permits it to be mass-produced and make it widely available for community testing, or door-to-door testing. Moreover, the cost-effectiveness of these kits as compared to RT-PCR-based assays, are also playing a pivotal role in bolstering the growth of the serological immunoassay technique.
Get sample copy of "COVID-19 Diagnostics Market" at: https://www.marketindustryreports.com/pdf/317
Major Key Players of the COVID-19 Diagnostics Market are:
Seegene Inc., F. Hoffmann-La Roche Ltd, altona Diagnostics GmbH, SD BIOSENSOR, Abbott, BIOMEDOMICS INC., Bio-Rad Laboratories, Inc., VivaChek Biotech (Hangzhou) Co., Ltd., Sensing Self, PTE. Ltd, Thermo Fisher Scientific, PerkinElmer Inc., among others.
To keep up to the demand for testing kits used for the detection of COVID-19, pharmaceutical, and biotech companies have substantially increased production capabilities. Moreover, these companies, along with research & medical institutes, and researchers & scientists worldwide, are inventing novel technologies to speed up the testing processess further. Government bodies across the globe have also taken several initiatives to fast-track the development of such products by providing necessary grants, permissions, clearances& approvals. For instance, on March 27, 2020, the U.S. Food and Drug Administration (FDA) granted "emergency use authorization" approval to Abbott's ID NOW COVID-19 test. The ID NOW COVID-19 test provides positive results in as little as five minutes and negative results in 13 minutes and can be used for point-of-caresettings.
Currently, the two major testing procedures for SARS-CoV-2 are the molecular assay and serology immunoassay technique. However, optimal use offew ancillary diagnostic practices like diagnostic imaging, biomarkers, and other non-microbiological tests have also been evolving in the testing of COVID-19, in recent times. Molecular assay technique, which includes both laboratory-based molecular testing and point-of-care molecular diagnostics, remains the front runner in the COVID-19 diagnostics market. These molecular diagnostic techniques make use of the Real-Time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR).
Major Test Types of COVID-19 Diagnostics Market covered are:
Molecular Assays
Serologic Immunoassays and Ancillary Diagnostic Tests
Major Applications of COVID-19 Diagnostics Market covered are:
Hospitals
Public Health Labs, and Private or Commercial Labs
Research objectives:-
– To study and analyze the global COVID-19 Diagnostics consumption (value & volume) by key regions/countries, product type and application, history data.
– To understand the structure of the COVID-19 Diagnostics market by identifying its various sub-segments.
– Focuses on the key global COVID-19 Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.
– To analyze the COVID-19 Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Go For Interesting Discount Here: https://www.marketindustryreports.com/discount/317
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.5 Market by Application
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 COVID-19 Diagnostics Market Size
2.2 COVID-19 Diagnostics Growth Trends by Regions
2.3 Industry Trends
3 Market Share by Key Players
3.1 COVID-19 Diagnostics Market Size by Manufacturers
3.2 COVID-19 Diagnostics Key Players Head office and Area Served
3.3 Key Players COVID-19 Diagnostics Product/Solution/Service
3.4 Date of Enter into COVID-19 Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global COVID-19 Diagnostics Sales by Product
4.2 Global COVID-19 Diagnostics Revenue by Product
4.3 COVID-19 Diagnostics Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global COVID-19 Diagnostics Breakdown Data by End User
Have any query? Inquiry about report at: https://www.marketindustryreports.com/inquiry/317
In the end, COVID-19 Diagnostics industry report specifics the major regions, market scenarios with the product price, volume, supply, revenue, production, and market growth rate, demand, forecast and so on. This report also presents SWOT analysis, investment feasibility analysis, and investment return analysis.
About Market Industry Reports
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, mega trends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Contact Us-
Email: sales@marketindustryreports.com
Phone: + 91 8956767535
Website: https://www.marketindustryreports.com
COVID-19 Diagnostics Market to Witness Huge Growth from 2019-2030 and Focusing on Top Key Players - F. Hoffmann-La Roche, Seegene, Abbott
Excerpts from Market Industry Reports (MIR) report titled “COVID-19 Diagnostics” predict the global COVID-19 diagnostics market to clock several billion by the end of the year 2020.